Author: Akudugu, John M.
Similar Items: Assessment of point-of-care testing for prediction of aromatase inhibitor-associated side effects in obese postmenopausal breast cancer patients screened for cardiovascular risk factors
- Bone health in post-menopausal patients with breast cancer treated with aromatase inhibitors: factors predicting the risk for osteoporosis.
- Investigating the effects of progestins used in contraception and menopausal hormone therapy on aromatase expression and activity
- CARDIOVASCULAR RISK FACTORS IN PREMENOPAUSAL WOMEN WITH BREAST CANCER AFTER OOPHORECTOMY
- An investigation into the effects of Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants on sperm parameters - an in vitro study
- Epacs exchange protein directly activated by cAMP role in obesity-induced cardiovascular diseases
- Sex hormones and their relationship with leptin and cardiovascular risk factors in pre and post-menopausal Nigerian women with metabolic syndrome